PTSD Clinical Trial

Study open to Veterans and Active-Duty Military with PTSD

We invite you to be part of a potentially groundbreaking research study testing medications for posttraumatic stress disorder (PTSD) funded by the US Department of Defense. By participating, you can contribute to potentially advancing knowledge and finding effective treatments for this condition.

At Advanced Discovery Research, we are committed to conducting impactful research. Our study aims to test FDA-approved medications used for other conditions and new investigational medications to determine their potential in alleviating PTSD symptoms.

Key Details:

Duration: 20 weeks, with the possibility of trying multiple investigational medications in a row, which will extend participation for 16 weeks for each investigational medication.
Eligibility: We are specifically seeking individuals aged 18-64 with PTSD who have served or are currently serving in the US military.
Study Procedures: If eligible, you will sign an informed consent form and be randomly assigned to an investigational treatment group. You may be assigned an active investigational medication or a placebo. Participation involves 4 in-person visits, 2 remote visits, and televisits for adjusting dosages, as applicable.
Confidentiality: Your information will be treated with strict confidentiality and in accordance with data protection regulations.

Your participation is entirely voluntary, and you can withdraw at any time without consequences. Enrolled participants will receive study-related medications and study-related assessments at no cost, along with compensation of up to $575 per study group.

If you are interested or would like more information, please complete the form below or contact us at S-21-02@advdiscovery.com or 470-777-8839. Our team is available to address any questions or concerns you may have.

Thank you for considering this opportunity to contribute to valuable research. Your involvement can potentially make a significant impact in advancing knowledge and potentially improving the lives of those affected by PTSD.